Adam P. Dicker

Active 1990–2025

129
Papers
19,923
Citations
81
h-index
126
i10-index

Citations

Citations per year for Adam P. Dicker1992: 1 citations1993: 4 citations1994: 5 citations1995: 4 citations1996: 5 citations1997: 11 citations1998: 9 citations1999: 14 citations2000: 19 citations2001: 22 citations2002: 29 citations2003: 29 citations2004: 33 citations2005: 38 citations2006: 35 citations2007: 41 citations2008: 48 citations2009: 39 citations2010: 53 citations2011: 74 citations2012: 64 citations2013: 84 citations2014: 114 citations2015: 126 citations2016: 202 citations2017: 175 citations2018: 157 citations2019: 679 citations2020: 779 citations2021: 824 citations2022: 613 citations2023: 463 citations2024: 795 citations2025: 391 citations2026: 22 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,725 citing papers, 27.1% of this breakdownChina: 709 citing papers, 7% of this breakdownUnited Kingdom: 621 citing papers, 6.2% of this breakdownCanada: 592 citing papers, 5.9% of this breakdownGermany: 521 citing papers, 5.2% of this breakdownItaly: 470 citing papers, 4.7% of this breakdownFrance: 357 citing papers, 3.5% of this breakdownNetherlands: 356 citing papers, 3.5% of this breakdownAustralia: 313 citing papers, 3.1% of this breakdownSwitzerland: 267 citing papers, 2.7% of this breakdownSpain: 251 citing papers, 2.5% of this breakdownBelgium: 232 citing papers, 2.3% of this breakdown
0%27.1%Other 26.3%

Fields

  • Medicine65.7%
  • Biochemistry, Genetics and Molecular Biology16.6%
  • Physics and Astronomy3.5%
  • Computer Science3.1%
  • Economics, Econometrics and Finance2.1%
  • Engineering1.5%
  • Other7.5%

Topics

  • Prostate Cancer Treatment and Research7.8%
  • Prostate Cancer Diagnosis and Treatment6%
  • Advanced Radiotherapy Techniques3.5%
  • Glioma Diagnosis and Treatment2.8%
  • Cancer Immunotherapy and Biomarkers2.6%
  • Brain Metastases and Treatment1.8%
  • Other75.5%

Coauthors

All papers

Open in search
  1. Federated learning enables big data for rare cancer boundary detection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John W. Garrett, Matthew Larson, Robert Jeraj, Stuart Currie, Russell Frood, Kavi Fatania, Raymond Y. Huang, Ken Chang, Carmen Balañá, Jaume Capellades, Josep Puig, Johannes Trenkler, Josef Pichler, Georg Necker, Andreas Haunschmidt, Stephan Meckel, Gaurav Shukla, Spencer Liem, Gregory S. Alexander, Joseph S. Lombardo, Joshua D. Palmer, Adam E. Flanders, Adam P. Dicker, Haris I. Sair, Craig Jones, Archana Venkataraman, Meirui Jiang, Tiffany Y. So, Cheng Chen, Pheng‐Ann Heng, Qi Dou, Michal Kozubek, Filip Lux, Jan Michálek, Petr Matula, Miloš Keřkovský, Tereza Kopřivová, Marek Dostál, Václav Vybíhal, Michael A. Vogelbaum, J. Ross Mitchell, Joaquim M. Farinhas, Joseph A. Maldjian, Chandan Ganesh Bangalore Yogananda, Marco C. Pinho, Divya Reddy, James Holcomb, Benjamin Wagner, Benjamin M. Ellingson, Timothy F. Cloughesy, Catalina Raymond, Talia C. Oughourlian, Akifumi Hagiwara, Chencai Wang, Minh‐Son To, Sargam Bhardwaj, Chee Chong, Marc Agzarian, Alexandre X. Falcão, Samuel Botter Martins, Bernardo Corrêa de Almeida Teixeira, F Sprenger, David Menotti, Diego Rafael Lucio, Pamela LaMontagne, Daniel S. Marcus, Benedikt Wiestler, Florian Kofler, Ivan Ezhov, Marie Metz and 179 more - Nature Communications 2022 cited by 340

  2. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2020 cited by 1,140

  3. The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William L. Dahut, Peter S. Nelson - Clinical Cancer Research 2019 cited by 394

  4. NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 199

  5. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 cited by 905

  6. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacqueline Powers, Raoul S. Concepcion, Daniel W. Lin, Richard C. Wender, James Ryan Mark, Anthony J. Costello, Arthur L. Burnett, Oliver Sartor, William B. Isaacs, Jianfeng Xu, Jeffrey N. Weitzel, Gerald L. Andriole, Himisha Beltran, Alberto Briganti, Lindsey Byrne, Anne Calvaresi, Thenappan Chandrasekar, David Y.T. Chen, Robert B. Den, Albert Dobi, E. David Crawford, James A. Eastham, Scott E. Eggener, Matthew L. Freedman, Marc B. Garnick, Patrick T. Gomella, Nathan Handley, Mark Hurwitz, Joseph K. Izes, R. Jeffrey Karnes, Costas D. Lallas, Lucia R. Languino, Stacy Loeb, Ana María López, Kevin R. Loughlin, Grace Lu‐Yao, S. Bruce Malkowicz, Mark Mann, Patrick Mille, Martin Miner, Todd M. Morgan, José Moreno, Lorelei A. Mucci, Ronald E. Myers, Sarah M. Nielsen, Brock O’Neil, Wayne H. Pinover, Peter A. Pinto, Wendy Poage, Ganesh V. Raj, Timothy R. Rebbeck, Charles J. Ryan, Howard M. Sandler, Matthew J. Schiewer, Emily Scott, Brittany M. Szymaniak, William Tester, Edouard J. Trabulsi, Neha Vapiwala, Evan Y. Yu, Charnita Zeigler‐Johnson, Leonard G. Gomella - Journal of Clinical Oncology 2020 cited by 279

  7. Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2023 cited by 120

  8. Dual Roles of PARP-1 Promote Cancer Growth and Progression

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2012 cited by 446

  9. Radiation Dose–Volume Effects in the Brain

    Authors: , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2010 cited by 744

  10. Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 cited by 655

  11. Innovations in research and clinical care using patient‐generated health data

    Authors: , , , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2020 cited by 150

  12. Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2021 cited by 148

  13. A Hormone–DNA Repair Circuit Governs the Response to Genotoxic Insult

    Authors: , , , , , , , , , , - Cancer Discovery 2013 cited by 368

  14. Histopathology‐validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo‐progression in glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer 2020 cited by 92

  15. Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade

    Authors: , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2022 cited by 43

  16. Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 250

  17. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2018 cited by 231

  18. Clinical Integration of Digital Solutions in Health Care: An Overview of the Current Landscape of Digital Technologies in Cancer Care

    Authors: , , , - JCO Clinical Cancer Informatics 2018 cited by 153

  19. Radiotherapy Protocol Deviations and Clinical Outcomes: A Meta-analysis of Cooperative Group Clinical Trials

    Authors: , , , , , - JNCI Journal of the National Cancer Institute 2013 cited by 315

  20. RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients

    Authors: , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2012 cited by 170

  21. The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules

    Authors: , , , , , , , - Cancer Growth and Metastasis 2018 cited by 163

  22. Vimentin is a novel AKT1 target mediating motility and invasion

    Authors: , , , , , , , , , , , , , , , - Oncogene 2010 cited by 247

  23. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 cited by 216

  24. Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zaid Haddad, Elai Davicioni, Edouard J. Trabulsi, Stacy Loeb, Ashutosh Tewari, Peter R. Carroll, Sheila Weinmann, Edward M. Schaeffer, Eric A. Klein, R. Jeffrey Karnes, Felix Y. Feng, Paul L. Nguyen - Journal of Clinical Oncology 2017 cited by 213